Vita Life Sciences Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: 0.125x

Vita Life Sciences Ltd cash flow conversion efficiency. Based on the latest financial reports, Vita Life Sciences Ltd (VLS) has a cash flow conversion efficiency ratio of 0.125x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$6.60 Million ≈ $4.67 Million USD) by net assets (AU$52.62 Million ≈ $37.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Vita Life Sciences Ltd (2006–2024)

Cash flow conversion efficiency of Vita Life Sciences Ltd from 2006 to 2024. This chart illustrates how Vita Life Sciences Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Vita Life Sciences Ltd stock price today for real-time trading data and today's change.

Vita Life Sciences Ltd Cash Flow Conversion Ratio Explained

Vita Life Sciences Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Vita Life Sciences Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vita Life Sciences Ltd ranked by their cash flow conversion efficiency. Also see VLS company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Yen Sun Technology TWO:6275	0.026x
Organogenesis Holdings Inc NASDAQ:ORGO	0.008x
Bank of the James Financial Group NASDAQ:BOTJ	0.024x
Fortune Oriental Co Ltd TW:2491	-0.211x
Optical Cable Corporation NASDAQ:OCC	0.062x
Shimmick Corporation Common Stock NASDAQ:SHIM	0.340x
Inovio Pharmaceuticals Inc NASDAQ:INO	2.795x
Faraday Future Intelligent Electric Inc NASDAQ:FFIE	-0.389x

Annual Cash Flow Conversion Efficiency for Vita Life Sciences Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Vita Life Sciences Ltd from 2006 to 2024. Review Vita Life Sciences Ltd (VLS) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$52.28 Million ≈ $36.99 Million	AU$6.16 Million ≈ $4.36 Million	0.118x	-60.71%
2023-12-31	AU$43.33 Million ≈ $30.66 Million	AU$12.98 Million ≈ $9.19 Million	0.300x	+294.10%
2022-12-31	AU$36.50 Million ≈ $25.83 Million	AU$2.77 Million ≈ $1.96 Million	0.076x	-60.73%
2021-12-31	AU$30.42 Million ≈ $21.53 Million	AU$5.89 Million ≈ $4.17 Million	0.194x	-37.28%
2020-12-31	AU$24.44 Million ≈ $17.29 Million	AU$7.54 Million ≈ $5.34 Million	0.309x	+242.94%
2019-12-31	AU$22.53 Million ≈ $15.94 Million	AU$2.03 Million ≈ $1.43 Million	0.090x	-29.04%
2018-12-31	AU$22.41 Million ≈ $15.85 Million	AU$2.84 Million ≈ $2.01 Million	0.127x	-2.28%
2017-12-31	AU$24.79 Million ≈ $17.54 Million	AU$3.22 Million ≈ $2.28 Million	0.130x	-36.14%
2016-12-31	AU$23.18 Million ≈ $16.40 Million	AU$4.71 Million ≈ $3.33 Million	0.203x	-5.56%
2015-12-31	AU$22.88 Million ≈ $16.19 Million	AU$4.92 Million ≈ $3.48 Million	0.215x	-24.11%
2014-12-31	AU$21.57 Million ≈ $15.26 Million	AU$6.12 Million ≈ $4.33 Million	0.284x	-4.59%
2013-12-31	AU$16.27 Million ≈ $11.51 Million	AU$4.83 Million ≈ $3.42 Million	0.297x	+143.73%
2012-12-31	AU$11.34 Million ≈ $8.03 Million	AU$1.38 Million ≈ $978.56K	0.122x	-80.71%
2011-12-31	AU$8.96 Million ≈ $6.34 Million	AU$5.66 Million ≈ $4.01 Million	0.632x	+712.81%
2010-12-31	AU$8.13 Million ≈ $5.75 Million	AU$-838.65K ≈ $-593.40K	-0.103x	+83.17%
2009-12-31	AU$3.90 Million ≈ $2.76 Million	AU$-2.39 Million ≈ $-1.69 Million	-0.613x	-515.31%
2008-12-31	AU$3.85 Million ≈ $2.72 Million	AU$567.42K ≈ $401.48K	0.148x	-43.35%
2007-12-31	AU$2.88 Million ≈ $2.04 Million	AU$750.00K ≈ $530.67K	0.260x	+68.96%
2006-12-31	AU$3.35 Million ≈ $2.37 Million	AU$516.00K ≈ $365.10K	0.154x	--

About Vita Life Sciences Ltd

AU:VLS Australia Drug Manufacturers - Specialty & Generic

Market Cap

$105.89 Million

AU$149.66 Million AUD

Market Cap Rank

#18776 Global

#581 in Australia

Share Price

AU$2.74

Change (1 day)

+0.00%

52-Week Range

AU$2.27 - AU$2.89

All Time High

AU$2.89